D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

OTLK holding history

Outlook Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OTLK overview All 13F holders of OTLK Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of OTLK by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−10,599−100.0%	Sold out	Holders
Q3 2022	10,599	$13.0K	<0.1%	+10,599	New	Holders
Q3 2021	0	$0	0.0%	−30,135−100.0%	Sold out	Holders
Q2 2021	30,135	$75.0K	<0.1%	+30,135	New	Holders